Sangharsh Lifecare Private Limited — Diclofenac Exporter Profile
Indian Pharmaceutical Exporter · #12 for Diclofenac · $1.2M export value · DGFT Verified
Sangharsh Lifecare Private Limited is the #12 Indian exporter of Diclofenac with $1.2M in export value and 24 verified shipments. Sangharsh Lifecare Private Limited holds a 0.3% market share in Diclofenac exports across 3 countries.
Sangharsh Lifecare Private Limited — Diclofenac Export Profile: Buyers & Destinations
Where Does Sangharsh Lifecare Private Limited Export Diclofenac?
Sangharsh Lifecare Private Limited exports Diclofenac to 3 countries. The largest destination is GHANA accounting for 72.4% of Sangharsh Lifecare Private Limited's Diclofenac shipments, followed by NIGERIA (25.4%) and BENIN (2.2%). These destinations reflect Sangharsh Lifecare Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Diclofenac from Sangharsh Lifecare Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| ZMC INTERNATIONAL LTD | NIGERIA | $88.8K | 2 |
| UGOLAB PRODUCTIONS NIGERIA LTD | NIGERIA | $50.0K | 1 |
| FREIGHTER MADE LOGISTICS LIMITED | NIGERIA | $20.0K | 2 |
| RAJSHEH MULTI GLOBAL CONCEPT | NIGERIA | $20.0K | 2 |
| MEDICROWN NIGERIA LTD | NIGERIA | $6.2K | 1 |
| ALIYU MEGA PHARMACEUTICALS NIGERIA | NIGERIA | $5.3K | 1 |
| YA'U MISBAHU | BENIN | $379 | 1 |
Sangharsh Lifecare Private Limited supplies Diclofenac to 7 buyers globally. The largest buyer is ZMC INTERNATIONAL LTD (NIGERIA), followed by UGOLAB PRODUCTIONS NIGERIA LTD (NIGERIA) and FREIGHTER MADE LOGISTICS LIMITED (NIGERIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Diclofenac Export Value and How Much Does Sangharsh Lifecare Private Limited Contribute?
India exported $119.5M worth of Diclofenac through 15,000 shipments from 1007 suppliers to 173 countries, serving 2,731 buyers globally. Sangharsh Lifecare Private Limited contributes $1.2M to this total, accounting for 0.3% of India's Diclofenac exports. Sangharsh Lifecare Private Limited ships Diclofenac to 3 countries through 7 buyers.
What Is the Average Shipment Value for Sangharsh Lifecare Private Limited's Diclofenac Exports?
Sangharsh Lifecare Private Limited's average Diclofenac shipment value is $50.0K per consignment, based on 24 shipments totaling $1.2M. The largest destination is GHANA (72.4% of Sangharsh Lifecare Private Limited's Diclofenac exports).
How Does Sangharsh Lifecare Private Limited Compare to Other Indian Diclofenac Exporters?
Sangharsh Lifecare Private Limited ranks #12 among 1007 Indian Diclofenac exporters with a 0.3% market share. The top 3 exporters are CIPLA LIMITED ($20.9M), TROIKAA PHARMACEUTICALS LIMITED ($16.0M), CAPLIN POINT LABORATORIES LIMITED ($15.5M). Sangharsh Lifecare Private Limited processed 24 shipments to 3 destination countries.
What Diclofenac Formulations Does Sangharsh Lifecare Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| DICLOFENAC SODIUM 50MG TABLET- DICLOSET | $542.1K | 15 |
| Labrelax Tablets( Diclofenac Potassium USP Tab 50mg) | $50.0K | 1 |
| Zimzugi Tablet (DICLOFENACPOTASSIUM TABLETS USP 50MG | $45.8K | 1 |
| ZYMTHROTEC TABLET (DICLOFENAC SODIUM 75MG & MISOPROSTOL 200MCG TABLET) | $42.9K | 1 |
| DICLOFENAC SODIUM BP 75MG & MISOPROSTOL 200MCG TAB ZYMTHROTEC TABLET BT-131801 MANUFACTURING -10/23EXP-09/26 | $20.0K | 2 |
| DICLOFENAC SODIUM BP 50MG TABLET (DICLOS | $16.4K | 3 |
| DICLOFENAC SODIUM BP 75MG & MISOPROSTOL | $10.0K | 1 |
| DICLOFENAC SODIUM BP 75MG & MISOPROSTOL 200MCG ASTHROTEC TABLET BT-12442 MANUFACTURING -10/23EXP-09/26 | $10.0K | 1 |
| BUMACAPS CAPSULES (DICLOFENAC SODIUM SRCAPSULES 100MG)NOS | $6.2K | 1 |
| RUMAFLAM -50 TABLET DICLOFENAC POTASSIU | $5.3K | 1 |
Sangharsh Lifecare Private Limited exports 11 distinct Diclofenac formulations including tablets, capsules, syrups, and combination drugs. The top formulation is DICLOFENAC SODIUM 50MG TABLET- DICLOSET with 15 shipments worth $542.1K.
Regulatory Requirements: Exporting Diclofenac to Key Markets
What Sangharsh Lifecare Private Limited must comply with to export Diclofenac to its top destination countries
Nigeria — NAFDAC
Approval Process
Drug registration under NAFDAC guidelines. WHO-type CPP from India required.
Timeline: 6–18 months
GMP & Export Requirements
WHO GMP compliance; NAFDAC conducts overseas plant inspections
Certificate of Pharmaceutical Product (CPP) from CDSCO India; NAFDAC import permit
Note: India is the largest pharma supplier to Nigeria. NAFDAC has intensified Indian site inspections.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Sangharsh Lifecare Private Limited Compare to Nearest Diclofenac Exporters?
Exporters ranked immediately above and below #12 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 10 | SIFAM HEALTHCARE PRIVATE LIMITED | $2.1M | 42 | 5 | $50.0K |
| 14 | ALEMBIC PHARMACEUTICALS LIMITED | $1.9M | 38 | 1 | $50.0K |
| 12 | SANGHARSH LIFECARE PRIVATE LIMITED ★ | $1.2M | 24 | 3 | $50.0K |
Sangharsh Lifecare Private Limited ranks #12 among 1007 Indian Diclofenac exporters. Average shipment value of $50.0K compared to the market average of $118.7K. The closest competitors by value are SIFAM HEALTHCARE PRIVATE LIMITED and ALEMBIC PHARMACEUTICALS LIMITED.
Which Indian Ports Ship Diclofenac Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 2,481 | 16.5% |
| JNPT/ NHAVA SHEVA SEA | 1,272 | 8.5% |
| SAHAR AIR CARGO ACC (INBOM4) | 1,186 | 7.9% |
| SAHAR AIR | 903 | 6.0% |
| JNPT | 712 | 4.7% |
| DELHI AIR CARGO ACC (INDEL4) | 679 | 4.5% |
| NHAVA SHEVA | 676 | 4.5% |
| Bombay Air | 491 | 3.3% |
Market Intelligence
Latest developments and market context
Detailed market intelligence for Diclofenac — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Diclofenac shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Sangharsh Lifecare Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 28 individual customs records matching Sangharsh Lifecare Private Limited exporting Diclofenac, covering 11 formulations to 3 countries via 7 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 173+ countries, 2,731+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Diclofenac Export Data from Sangharsh Lifecare Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Sangharsh Lifecare Private Limited's Diclofenac exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Sangharsh Lifecare Private Limited
Company Profile
0 products · $0 total trade · 0 categories
Diclofenac Stats
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Sangharsh Lifecare Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Diclofenac. For current shipment-level data, contact TransData Nexus.